fashion -WSS

fashion

author：comprehensive 2025-09-29 18:17:09 - browse：944

Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： CEOs share strategies for surviving biotech slump

WSS

Copay coupons to count toward deductibles, after Biden court move

Readout Newsletter: Merck, J&J, and long Covid

CEOs share strategies for surviving biotech slump

STAT Summit: Michael J. Fox on progress in Parkinson's research

FDA warns J&J's Abiomed: We will regulate your software

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

focus

fashion

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage today, explained in one chart

23andMe had bad news about my health. I wish a person had delivered it

Test for long Covid? Researchers find new clue in blood samples

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Merck, J&J, and long Covid

Bright Health sells Medicare Advantage business to Molina

AI generated plenty of interest at JPM but not a lot of trust

hotspot

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

FDA warns J&J's Abiomed: We will regulate your software

Why doctors need education on FDA device approval process

Think you might have Covid

Medicare reduced heart disease by changing how it pays doctors

Elizabeth Holmes banned from government health programs

Wikipedia

entertainment

explore

focus